General Information of Drug (ID: DMKPYEU)

Drug Name
N-[3,3-Bis-(4-fluorophenyl)-propyl]-benzamide Drug Info
Synonyms
N-(3,3-diphenylpropyl)benzamide; CHEMBL556303; AC1LOGD3; Oprea1_468003; N-[3,3-Bis-(4-fluorophenyl)-propyl]-benzamide; SCHEMBL5948102; MolPort-001-492-275; ZINC995229; STK448927; BDBM50297396; AKOS003256160; MCULE-7987321913; ST50916006
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
1220236
TTD Drug ID
DMKPYEU

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Soluble epoxide hydrolase (EPHX2) TT7WVHI HYES_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Soluble epoxide hydrolase (EPHX2) DTT EPHX2 8.353 7.227 6.421 8.192
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Soluble epoxide hydrolase (EPHX2) DTT EPHX2 8.78E-01 -0.1 -0.27
Soluble epoxide hydrolase (EPHX2) DTT EPHX2 4.40E-02 -0.18 -0.42
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J Med Chem. 2009 Oct 8;52(19):5880-95.